2021
Safety considerations for esophageal dilation by anesthetic type: A systematic review
Lerner MZ, Bourdillon AT, Dai F, Brackett A, Kohli N. Safety considerations for esophageal dilation by anesthetic type: A systematic review. American Journal Of Otolaryngology 2021, 42: 103128. PMID: 34216877, DOI: 10.1016/j.amjoto.2021.103128.Peer-Reviewed Original ResearchConceptsEsophageal dilationOffice-based techniqueSystematic reviewDerSimonian-Laird random-effects modelType of anesthesiaSmall case seriesOffice-based proceduresFull-text studiesUse of stentsRandom-effects modelComprehensive literature searchInverse variance weightingAdverse eventsAnesthetic typeCase seriesIntravenous sedationGeneral anesthesiaHigh morbidityAnesthesia techniquesLocal anesthesiaEmbase databasesExclusion criteriaEquivalent safetyPRISMA guidelinesRare disease
2020
Incidental Otolaryngologic Pathology Noted Upon Esophagogastroduodenoscopy: Case Series and Review of Literature
Macdonald EJ, Lerner BA, Lerner MZ. Incidental Otolaryngologic Pathology Noted Upon Esophagogastroduodenoscopy: Case Series and Review of Literature. Cureus 2020, 12: e11866. PMID: 33409100, PMCID: PMC7781552, DOI: 10.7759/cureus.11866.Peer-Reviewed Case Reports and Technical NotesOtolaryngologic pathologiesFollowing anatomic sitesBase of tongueAirway foreign bodiesNature of referralsInterarytenoid mucosaOtolaryngologic evaluationReview of literatureChart reviewUpper endoscopyAdult patientsOtolaryngology consultationCase seriesUnnecessary referralsPatient anxietyAnatomic variantsAnatomic sitesEsophagogastroduodenoscopySoft palateForeign bodyNeck pathologyTrue pathologyNormal anatomyGastroenterologistsEarly detection
2017
Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients
Lerner MZ, Mor N, Paek H, Blitzer A, Strome M. Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients. Annals Of Otology Rhinology & Laryngology 2017, 126: 340-343. PMID: 28103701, DOI: 10.1177/0003489416688478.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaAdjuvant metformin therapyHNC patientsMetformin therapyDiabetes mellitusOral cavity squamous cell carcinomaType 2 diabetes mellitusLaryngeal squamous cell carcinomaOral anti-hyperglycemic agentAbnormal glucose metabolismRisk of malignancyAnti-hyperglycemic agentsMultifocal dysplastic lesionsNondiabetic patientsAdjuvant therapyNondiabetic populationOverall survivalAdditional surgeryMucosal lesionsCase seriesOral lesionsCell carcinomaNeck cancerDysplastic lesionsDysplastic mucosa